Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Event: ESC Congress 2022
Topic: Anticoagulants
Session: Challenges and advances in antithrombotic therapy
ESC 365 is supported by
